Which investor invests in what?

Corporate venture arm of Cereal Docks Group investing from early-stage and seed up to Series A in B2B food technology and sustainable functional ingredients.

Kind

Corporate venture capital

Stages

Pre-seed · Seed · Series A · Series B

Countries

Any country

Key fact

Typical round €5M

Last verified

Verified 8 Nov 2026

Achmea Impact Ventures provides €50k to €200k convertible loan funding and expert support to early-stage digital startups in health, work, finance, and living.

Kind

Corporate venture capital

Stages

Idea · Pre-seed · Seed

Countries

Any country

Key fact

Ticket €50K–€200K

Last verified

Verified 7 Nov 2026

Sella Group

Corporate venture arm of Italy's Sella Group providing €250k–€500k in follower tickets to European and Italian early-stage fintech, AI-driven financial solutions, and market infrastructure startups.

Kind

Corporate venture capital

Stages

Seed · Series A

Countries

EU-wide, GB

Key fact

Ticket €250K–€500K

Last verified

Verified 7 Nov 2026

Corporate venture arm of Angelini Industries investing in Series A and Series B rounds of biotech and healthtech companies across Europe and North America.

Kind

Corporate venture capital

Stages

Series A · Series B

Countries

Any country

Key fact

Typical round €51.9M

Last verified

Verified 7 Nov 2026

Roche

Corporate venture capital fund of Roche investing CHF 3–10m primarily in Series A rounds of life sciences, therapeutics, diagnostics, and healthcare technology companies.

Kind

Corporate venture capital

Stages

Series A

Countries

Any country

Key fact

Ticket €3.3M–€10.9M

Last verified

Verified 7 Nov 2026

ISAI

ISAI Cap Venture is a partnership between ISAI and Capgemini co-investing €1M to €5M in Series A–C enterprise software companies with synergies for Capgemini.

Kind

Corporate venture capital

Stages

Seed · Series A · Series B · Series C+

Countries

Any country

Key fact

Ticket €1M–€5M

Last verified

Verified 7 Nov 2026

Belgian impact-first fund backed by CM investing in healthcare innovation. Provides equity or convertible loans to seed and Series A companies focused on sustainable care and positive health.

Kind

Corporate venture capital

Stages

Seed · Series A

Countries

Belgium

Key fact

Ticket up to €500K

Last verified

Verified 7 Nov 2026

Strategic investment arm of Gateway Group providing growth capital co-investments alongside lead investors, combined with dedicated software engineering and GTM capacity for Dutch scale-ups.

Kind

Corporate venture capital

Stages

Series B · Series C+

Countries

Netherlands

Last verified

Verified 7 Nov 2026

Rabo Investments

Strategic investment arm of Rabobank investing €1m to €5m in early-stage FinTech and sustainability ventures at Seed, Series A, and Series B stages.

Kind

Corporate venture capital

Stages

Seed · Series A · Series B

Countries

Any country

Key fact

Ticket €1M–€5M

Last verified

Verified 7 Nov 2026

Coöperatie VGZ

Corporate venture fund of Dutch health insurer VGZ investing in medtech, healthtech, and digital health services that improve healthcare accessibility and affordability.

Kind

Corporate venture capital

Stages

Pre-seed · Seed · Series B · Series C+

Countries

Any country

Last verified

Verified 7 Nov 2026

PTT Global Chemical

Corporate venture capital arm of PTT Global Chemical investing globally in startups from early stage to commercial scale-up across advanced materials, cleantech, biotech, and digital platforms.

Kind

Corporate venture capital

Stages

Pre-seed · Seed

Countries

Any country

Last verified

Verified 7 Nov 2026

Demcon

Demcon Investment is the corporate venture arm of Demcon holding, investing in deep tech and engineering-driven startups seeking technical co-development, contract manufacturing, and growth capital.

Kind

Corporate venture capital

Stages

Seed · Series A · Series B

Countries

Netherlands

Key fact

Ticket €100K–€2.5M

Last verified

Verified 7 Nov 2026

KPN

KPN Ventures is the corporate venture capital fund of Dutch telecom operator KPN. It invests in startups and scaleups focused on IoT, cybersecurity, digital healthcare, cloud computing, network technologies, and artificial intelligence.

Kind

Corporate venture capital

Stages

Series A

Countries

Any country

Last verified

Verified 7 Nov 2026

Capgemini

Corporate venture arm of Capgemini, investing minority stakes in B2B startups globally through the ISAI Cap Venture Fund and supporting joint go-to-market.

Kind

Corporate venture capital

Stages

Series B

Countries

Any country

Last verified

Verified 7 Nov 2026

Corporate venture arm of NETZSCH offering pre-seed and seed capital along with R&D, manufacturing expertise, and venture building support for B2B deep tech startups.

Kind

Corporate venture capital

Stages

Pre-seed · Seed

Countries

Any country

Key fact

Ticket €150K–€1M

Last verified

Verified 7 Nov 2026

Amsterdam-based corporate-backed venture capital fund investing in Seed and Series A startups across biotech, life sciences tools, healthcare, and enabling technologies.

Kind

Corporate venture capital

Stages

Seed · Series A · Series B · Series C+

Countries

Any country

Key fact

Ticket €445.5K–€2.7M

Last verified

Verified 7 Nov 2026

US-headquartered global venture fund backed by OCP Group and UM6P, investing in early- and growth-stage companies transforming agriculture, industrials, and mining.

Kind

Corporate venture capital

Stages

Pre-seed · Seed · Series B · Series C+

Countries

Any country

Last verified

Verified 7 Nov 2026

Innovation Industries

Corporate venture arm of Randstad investing in early- to expansion-stage startups across HR technology, worktech, edtech, fintech, and AI/ML.

Kind

Corporate venture capital

Stages

Pre-seed · Seed · Series A · Series B · Series C+

Countries

Any country

Key fact

Ticket €10.8M–€10.8M

Last verified

Verified 7 Nov 2026

GV

Venture capital arm of Alphabet investing across AI applications, healthcare, developer tools, cybersecurity, and computing infrastructure.

Kind

Corporate venture capital

Stages

Series B · Series C+

Countries

Any country

Key fact

Typical round €89.6M

Last verified

Verified 7 Nov 2026

Corporate venture capital and commercialization arm of UPMC investing across early- to growth-stage in healthcare diagnostics, therapeutics, and digital health solutions.

Kind

Corporate venture capital

Stages

Pre-seed · Seed · Series A · Series B · Series C+

Countries

Any country

Last verified

Verified 7 Nov 2026